The Food and Drug Administration oversees a broad range of medical and consumer products. In fact, the agency estimates that up to a quarter of all U.S. consumer spending is on FDA-regulated items. The Pew Charitable Trusts understands the tremendous impact these products have on public health. This project complements our work supporting drug safety and effective and efficient regulation of medical devices by focusing attention on over-the-counter drugs and dietary supplements, as well as fields such as regenerative medicine, in order to safeguard consumers and patients.
Our WorkView All
The Pew Charitable Trusts and several partner organizations sent a joint letter of support in advance of the House Energy and Commerce Committee’s markup on May 9 of H.R. 5333, a bill that would reform regulation of over-the-counter (OTC) drugs. Read More
Americans routinely use over-the-counter (OTC) drugs to treat a wide variety of ailments, but the Food and Drug Administration’s system for regulating most of these medications is unable to respond quickly to consumer safety concerns. That’s because updating or changing an OTC product’s FDA-approved recipe—known as a monograph—requires notice and comment rule-making,... Read More
The Pew Charitable Trusts, the American Academy of Pediatrics, the American Academy of Allergy, Asthma, and Immunology, the American Public Health Association, the Consumer Healthcare Products Association, the National Association of County and City Health Officials, and the Society for Maternal-Fetal Medicine thanked Senators Johnny Isakson (R-GA) and Bob Casey (D-PA) in an April 23 letter for... Read More